Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HER2-PET as a diagnostic tool in breast cancer patients with a clinical dilemma
2012-003789-41Phase 2Suspended
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by University Medical Center Groningen. Started Aug 2013; status: suspended.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-003789-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003789-41.